News | March 02, 2026
Emcure partners with Roche to boost nephrology and transplant care in India
Emcure to distribute Roche's kidney transplant and anemia drugs in India
Emcure to distribute Roche's kidney transplant and anemia drugs in India
AINU is set to accelerate its expansion footprint, enhance operational capabilities
AHH will make an investment of Rs. 600 crore in the company through a mix of primary and secondary infusion
AstraZeneca and Indian Society of Nephrology aim to help clinicians and healthcare practitioners to provide holistic kidney care to their patients.
Desidustat is currently approved only in India as OxemiaTM for patients with CKD induced anemia
Under this year’s theme of ‘Kidney Health For All’, ISN along with AstraZeneca aims to generate large scale awareness and educate people about ways to improve kidney health
Asahi Kasei is consistently pursuing its strategy of building a focused, sustainable specialty pharmaceutical platform for immunocompromised and medically complex patient groups
The study, which enrolled 35 Japanese patients, evaluated the percent change from baseline in the 24-hour urine protein-to-creatinine ratio
Renalyx will continue operating as an independent unit within the group
Deceased donor kidney transplants are time-critical, and it is uncommon to attempt them robotically
Subscribe To Our Newsletter & Stay Updated
